We determined here that a combined activin and TGF-β ligand expression score in the tumor was strongly predictive for shorter overall survival in our cohort, however, currently, there are no studies which simultaneously measures tumor and systemic ligand levels to determine if serum ligand levels reflect tumor ligand levels. The gene discussed is INHBE; the disease is neoplasm.